LEADER 01274oam  2200373   450 
001 9910712951603321
005 20200306114437.0
035   $a(CKB)5470000002498677
035   $a(OCoLC)1143391558
035   $a(EXLCZ)995470000002498677
100   $a20200306d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFunding the global benefits to biopharmaceutical innovation /$fThe Council of Economic Advisers
210  1$a[Washington, D.C.] :$cThe Council of Economic Advisers,$d2020.
215   $a1 online resource (23 pages) $ccolor illustrations
300   $a"Februrary 2020."
320   $aIncludes bibliographical references (pages 21-23).
606   $aDrug development$xEconomic aspects
606   $aBiopharmaceutics$xEconomic aspects
606   $aPharmaceutical industry$xPrices
615  0$aDrug development$xEconomic aspects.
615  0$aBiopharmaceutics$xEconomic aspects.
615  0$aPharmaceutical industry$xPrices.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910712951603321
996   $aFunding the global benefits to biopharmaceutical innovation$93250427
997   $aUNINA